Related Experiment Videos
[Circulating immune complexes, detection in human glomerulonephritis by the PEG-EDTA technique (author's transl)]
Pathologie-Biologie
|March 1, 1982
Summary
This study found that detecting circulating immune complexes (CIC) that fix C1q in glomerulonephritis (GN) patients is a valuable diagnostic tool. This method correlates with chronic kidney disease and complement system activation, aiding in immunopathologic investigation.
Area of Science:
- Nephrology
- Immunology
- Clinical Chemistry
Background:
- Glomerulonephritis (GN) is a complex kidney disease often involving immune system dysregulation.
- Circulating immune complexes (CIC) are implicated in the pathogenesis of various GN types.
- Accurate detection of CIC is crucial for understanding disease mechanisms and guiding treatment.
Purpose of the Study:
- To evaluate a novel method for detecting C1q-fixing CIC in patients with GN.
- To correlate the presence of C1q-fixing CIC with clinical, serological, and pathological findings in GN.
- To assess the utility of this technique as a routine diagnostic tool in human GN.
Main Methods:
- Prospective screening of 128 GN patient sera for C1q-fixing CIC using C1q precipitation with polyethylene glycol (PEG).
- Quantification of precipitated C1q by Mancini method, with a threshold of <27% for positivity.
- Correlation analysis of CIC results with clinical parameters (creatinine), complement levels (C3, C4, C1q), and glomerular deposits.
Main Results:
- 27% (35/128) of GN patients tested positive for C1q-fixing CIC.
- Higher positivity rates observed in Systemic Lupus Erythematosus (SLE) (67%) and membranoproliferative GN (54%).
- Presence of C1q-fixing CIC significantly correlated with chronic renal failure, hypocomplementemia, C3 and C4 activation, and glomerular C3, C4, and C1q deposition.
Conclusions:
- The C1q precipitation assay is a simple and effective method for detecting C1q-fixing CIC in GN.
- This detection method serves as a significant immunopathologic marker, correlating with disease severity and complement activation.
- Routine screening for C1q-fixing CIC can enhance the diagnostic workup of human glomerulonephritis.